Skip to content

The effect of bioactive compound supplementation on obesity treatment

Bioactive compounds supplementation effects on the gene expression of inflammatory markers and macrophage infiltration in obese women

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
REBEC
Registry ID
RBR-22pqs9
Enrollment
Unknown
Registered
2019-12-17
Start date
2019-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Women should consume twice a day, three capsules of 500mg after the big meals, totaling six capsules per day (3000mg) of: - 95% curcuminoid oil - krill oil (ratio of 900 mg of eicosapentaenoic acid an
Dietary supplement

Sponsors

Flávia Campos Corgosinho
Lead Sponsor
Faculdade de Nutrição - Universidade Federal de Goiás (FANUT-UFG)
Collaborator

Eligibility

Sex/Gender
Female
Age
20 Years to 59 Years

Inclusion criteria

Inclusion criteria: Obese women with BMI above 40kg / m² between 20 and 59 years of age.

Exclusion criteria

Exclusion criteria: Presence of acute inflammatory diseases; infectious diseases; neoplastic diseases; genetic syndromes; present age under 20 years; chronic consumption of vitamin supplements; alcohol (> 30g / day) (SBD, 2017); illicit drugs; do not live in the metropolitan region of goiania; swallowing problems and presenting any kind of intolerance or allergies to food supplement sources.

Design outcomes

Primary

MeasureTime frame
Infiltration of macrophages and morphology of adipocytes in the visceral and subcutaneous adipose tissue: evaluated by immunohistochemistry and the size of the adipocytes will be analyzed as well as the concentration of macrophages by area

Secondary

MeasureTime frame
metabolic profile will be evaluated by performing biochemical tests (fasting glycemia, glycosylated hemoglobin, lipidogram, glutamic-oxalacetic transaminase (GOT), glutamic-pyruvic transaminase (TGP) and C-reactive protein (CRP)) before and after the supplementation of bioactive compounds.;Gene expression of proinflammatory cytokines in subcutaneous and omental adipose tissue: will be evaluated by real-time polymerase chain reaction (qRT-PCR).;Expression of microRNAs related to the translation control of proteins important for inflammation will be evaluated in plasma, omental and subcutaneous adipose tissue samples by real-time polymerase chain reaction (qPCR);Degree of non-alcoholic hepatic steatosis: the liver will be analyzed by ultrasound that will be performed at baseline and post supplementation by an experienced radiologist who will classify steatosis as mild, moderate or severe.;Analysis of the inflammatory profile: interleukins 6 (IL-6), 10 (IL-10), Alpha Tumor Necrosis Factor (TNF-?), Gamma Peroxisome Proliferator Activated Receptor (PPAR-gamma), by enzyme-linked immunosorbent assay

Countries

Brazil

Contacts

Public ContactFlavia Corgosinho

Faculdade de Nutrição - Universidade Federal de Goiás (FANUT-UFG)

flaviacorgosinho@hotmail.com+55 011 949614847

Outcome results

None listed

Source: REBEC (via WHO ICTRP)